A recent RNA interference screen to find specific epigenetic vulnerabilities created by the SS18‐SSX oncoprotein identified a critical role for KDM2B, a member of the non‐canonical polycomb repressive complex 1 (PRC1.1) in sustaining SS cell proliferation (Banito et al, 2018). Here, KDM2B is linked to synovial sarcoma.